Literature DB >> 1975252

Absence of H-ras point mutation at codon 12 in N-methyl-N-nitrosourea-induced hepatocellular neoplasms in the rat.

H Li1, G H Lee, L X Cui, J Liu, K Nomura, K Ohtake, T Kitagawa.   

Abstract

In order to assess the possibility that activated ras-associated hepatic carcinomas might be much rarer in rats than mice because of the more frequent or rapid occurrence of powerful carcinogenic event(s) other than ras point mutations in the former animals, precancerous lesions and hepatocellular carcinomas induced by a weak hepatocarcinogen N-methyl-N-nitrosourea (MNU) in the rat liver were analyzed for the presence or absence of ras point mutations. MNU was chosen because it is well known that MNU-induced rat mammary carcinomas contain activated H-ras at very high frequency. Male Fisher rats were treated with a single dose of MNU after partial hepatectomy, and then administered dietary phenobarbital or repeated s.c. injections of carbon tetrachloride as promoting procedures. Analyses by oligonucleotide hybridization, MnlI-restriction-fragment-length polymorphism and NIH3T3 cell transfection assays revealed neither H-ras point mutations nor transforming ability of the DNA from 36 MNU-induced rat hepatic neoplasms. The results were in agreement with previous results for rat hepatocellular carcinomas induced by other potent liver carcinogens and did not support our hypothesis that the frequency of finding ras activation might be dependent on the strength of the carcinogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975252     DOI: 10.1007/bf01612914

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Glutathione transferases as markers of preneoplasia and neoplasia.

Authors:  K Sato
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

2.  Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.

Authors:  G McMahon; L Hanson; J J Lee; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Hereditary cancer, oncogenes, and antioncogenes.

Authors:  A G Knudson
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

Review 4.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

5.  Expression of cellular oncogenes during embryonic and fetal development of the mouse.

Authors:  D J Slamon; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

Review 6.  Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture.

Authors:  E Farber
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

7.  Induction of hepatocellular carcinoma in rat liver by initial treatment with benzo(a)pyrene after partial hepatectomy and promotion by phenobarbital.

Authors:  T Kitagawa; T Hirakawa; T Ishikawa; N Nemoto; S Takayama
Journal:  Toxicol Lett       Date:  1980-08       Impact factor: 4.372

8.  Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse.

Authors:  S H Reynolds; S J Stowers; R R Maronpot; M W Anderson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

9.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

10.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.

Authors:  H Zarbl; S Sukumar; A V Arthur; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

View more
  4 in total

1.  Carcinogen-induced liver tumours of Wistar rats: absence of activated ras genes and of N-rasC.

Authors:  R Ostermayr; B Suchy; H M Rabes
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.

Authors:  K Matsumoto; T Iwase; I Hirono; Y Nishida; Y Iwahori; T Hori; M Asamoto; N Takasuka; D J Kim; T Ushijima; M Nagao; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1997-02

3.  Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine.

Authors:  M Tsutsumi; Y Murakami; S Kondoh; T Tsujiuchi; K Hohnoki; K Horiguchi; O Noguchi; E Kobayashi; S Okita; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1993-09

4.  In vitro progression-associated c-H-ras activation in neoplastic hepatocyte lines established from SV40-T antigen gene-harboring transgenic mice.

Authors:  H Li; J Liu; K Nomura; G H Lee; O Hino; K Ohtake; S Aizawa; T Kitagawa
Journal:  Jpn J Cancer Res       Date:  1991-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.